CareMax, Inc.
CMAXNASDAQHealthcare
$0.42
+$0.42(+100.00%)
Market Cap$1607904
P/E Ratio—
52W High$0.52
52W Low$0.4215
CareMax, Inc. (CMAX) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CMAX · earnings · updated Jun 9, 2026
Latest Earnings
Q3 FY2024Report Date: Aug 9, 2024EPS Actual
-$10.48
Est. -$7.51 · -39.5%
Revenue
$0.20B
Est. $0.22B · -10.3%
Fiscal Period
Q3 FY2024
FY ends December
Report Date
Aug 9, 2024
After Market Close
▼ Miss EPS▼ Miss Revenue
CMAX reports quarterly as a NASDAQ-listed Medical - Healthcare Information Services company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$3.83
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$3.83
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2025 | Aug 7, 2025 | — | — | — | — | — | — |
| ◌ Q2 FY2025 | May 7, 2025 | — | — | — | — | — | — |
| ◌ Q4 FY2024 | Dec 5, 2024 | -$6.81 | — | — | — | $0.17B | — |
| ◌ Q4 FY2024 | Nov 14, 2024 | -$6.81 | — | — | — | $0.17B | — |
| ▼ Q3 FY2024 | Aug 9, 2024 | -$7.51 | -$10.48 | -39.5% | $0.20B | $0.22B | -10.3% |
| ▼ Q2 FY2024 | May 9, 2024 | -$8.73 | -$10.99 | -25.9% | $0.23B | $0.20B | +17.8% |
| — Q2 FY2024 | Apr 29, 2024 | — | -$124.53 | — | $0.15B | — | — |
| ▼ Q4 FY2023 | Nov 9, 2023 | -$2.40 | -$6.31 | -162.9% | $0.20B | $0.19B | +6.7% |
Q3 FY2025
Aug 7, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2025
May 7, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q4 FY2024
Dec 5, 2024
EPS Actual
—
EPS Est.
-$6.81
EPS Surpr.
—
Revenue
—
Q4 FY2024
Nov 14, 2024
EPS Actual
—
EPS Est.
-$6.81
EPS Surpr.
—
Revenue
—
Q3 FY2024
Aug 9, 2024Miss
EPS Actual
-$10.48
EPS Est.
-$7.51
EPS Surpr.
-39.5%
Revenue
$0.20B
Q2 FY2024
May 9, 2024Miss
EPS Actual
-$10.99
EPS Est.
-$8.73
EPS Surpr.
-25.9%
Revenue
$0.23B
Q2 FY2024
Apr 29, 2024
EPS Actual
-$124.53
EPS Est.
—
EPS Surpr.
—
Revenue
$0.15B
Q4 FY2023
Nov 9, 2023Miss
EPS Actual
-$6.31
EPS Est.
-$2.40
EPS Surpr.
-162.9%
Revenue
$0.20B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $-0.94 | $-0.94 | $-0.94 | 1 |
| Q3 FY2026 | $-1.32 | $-1.32 | $-1.32 | 1 |
| Q2 FY2026 | $-1.77 | $-1.77 | $-1.77 | 1 |
| Q1 FY2026 | $-2.05 | $-2.05 | $-2.05 | 1 |
| Q4 FY2025 | $-3.94 | $-3.94 | $-3.94 | 1 |
| Q3 FY2025 | $-4.65 | $-4.65 | $-4.65 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2026 | $0.3B | $0.3B | $0.3B | 1 |
| Q3 FY2026 | $0.3B | $0.3B | $0.3B | 1 |
| Q2 FY2026 | $0.4B | $0.4B | $0.4B | 1 |
| Q1 FY2026 | $0.3B | $0.3B | $0.3B | 1 |
| Q4 FY2025 | $0.3B | $0.3B | $0.3B | 1 |
| Q3 FY2025 | $0.3B | $0.3B | $0.3B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q3 FY2024 | Aug 9, 2024 | -39.5% | $4.46 | $4.54 | +1.79% |
| ▼ Q2 FY2024 | May 9, 2024 | -25.9% | $3.32 | $3.01 | -9.34% |
| — Q2 FY2024 | Apr 29, 2024 | — | $3.12 | $3.30 | +5.77% |
| ▼ Q4 FY2023 | Nov 9, 2023 | -162.9% | $51.15 | $43.95 | -14.08% |
| ▼ Q3 FY2023 | Aug 9, 2023 | -150.0% | $82.50 | $80.10 | -2.91% |
| ▼ Q2 FY2023 | May 10, 2023 | -20.2% | $76.20 | $84.00 | +10.24% |
| — Q1 FY2023 | Mar 30, 2023 | — | $75.90 | $73.80 | -2.77% |
| ▼ Q1 FY2023 | Mar 9, 2023 | -433.3% | $123.30 | $117.60 | -4.62% |
Q3 FY2024+1.79%
Report Date
Aug 9, 2024
EPS Beat/Miss
-39.5%
Price Before
$4.46
Price After
$4.54
Q2 FY2024-9.34%
Report Date
May 9, 2024
EPS Beat/Miss
-25.9%
Price Before
$3.32
Price After
$3.01
Q2 FY2024+5.77%
Report Date
Apr 29, 2024
EPS Beat/Miss
—
Price Before
$3.12
Price After
$3.30
Q4 FY2023-14.08%
Report Date
Nov 9, 2023
EPS Beat/Miss
-162.9%
Price Before
$51.15
Price After
$43.95
Q3 FY2023-2.91%
Report Date
Aug 9, 2023
EPS Beat/Miss
-150.0%
Price Before
$82.50
Price After
$80.10
Q2 FY2023+10.24%
Report Date
May 10, 2023
EPS Beat/Miss
-20.2%
Price Before
$76.20
Price After
$84.00
Q1 FY2023-2.77%
Report Date
Mar 30, 2023
EPS Beat/Miss
—
Price Before
$75.90
Price After
$73.80
Q1 FY2023-4.62%
Report Date
Mar 9, 2023
EPS Beat/Miss
-433.3%
Price Before
$123.30
Price After
$117.60
Avg Miss Reaction-3.15%
Beat Rate0 / 8 quarters
Largest Move-14.08% (Q4 FY2023)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CMAX ends December
CareMax, Inc. (CMAX) most recently reported earnings on August 9, 2024 for Q3 FY2024, posting EPS of $-10.48 — missing the analyst consensus of $-7.51 by -39.5%. The next CMAX earnings date is expected around September 1, 2026.
Each quarter, investors track CMAX earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CMAX revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CMAX's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CMAX earnings · 5 questionsCareMax, Inc.'s next earnings report is expected around September 1, 2026. CMAX typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CMAX historically reports after market close (AMC).
CMAX earnings datewhen is CMAX earningsCMAX next earnings datewhen does CMAX report earningsCMAX earnings calendar
▸ Source: FMP · CareMax, Inc. SEC filings · US GAAP · CareMax, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026